Brief Report: Aumolertinib as a Switch Therapy in Osimertinib-Intolerant NSCLC—The ACTIVE Trial

Journal of Thoracic Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles